2014
DOI: 10.5507/bp.2013.013
|View full text |Cite
|
Sign up to set email alerts
|

The effect of nano-scale topography on osteogenic differentiation of mesenchymal stem cells

Abstract: Background. Large bone defects resulting from trauma or disease pose a threat to humans. Thus far, tissue engineering as an important clinical approach uses cells, growth factors and scaffolds to regenerate large areas of damaged bone tissue. Since bone is a nanocomposite structure, it is assumed that nanomaterial scaffolds can induce or promote osteogenesis by mimicking the cell niche at nano level. Methods and Results. In this review we highlighted the effect of nano-scale topography on osteogenic differenti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
8
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 25 publications
(9 citation statements)
references
References 192 publications
0
8
0
1
Order By: Relevance
“…Osteoblasts are derived from the osteogenic differentiation of mesenchymal stem cells (MSCs) in different regulatory processes [1]. Moreover, osteogenic differentiation of MSCs is a complex process, correlating to numerous environmental factors, like hormones and growth factors [2]. MSC osteogenic differentiation is pivotal for bone disease treatment and the repair of bone defect [3].…”
Section: Introductionmentioning
confidence: 99%
“…Osteoblasts are derived from the osteogenic differentiation of mesenchymal stem cells (MSCs) in different regulatory processes [1]. Moreover, osteogenic differentiation of MSCs is a complex process, correlating to numerous environmental factors, like hormones and growth factors [2]. MSC osteogenic differentiation is pivotal for bone disease treatment and the repair of bone defect [3].…”
Section: Introductionmentioning
confidence: 99%
“…Incomplete regeneration of large bone segmental defects is associated with either the inadequate migration of mesenchymal stem cells (MSCs) into the defect site or the inability of the migrated MSCs to fully differentiate into osteogenic precursor cells . Differentiation of MSCs toward osteoblasts and other bone precursor cells is demanding in tissue engineering (TE) to successfully reconstruct large bone defects in vivo without any growth factors or osteogenic inducing medium . Various strategies that include physical stimuli (i.e., electrical and magnetic fields, heat treatment, mechanical forces, ultrasound, and laser irradiation), co‐culturing system, natural extracellular matrix and cytoplasmic extracts, small molecules, and genetic manipulation, have been used to direct the differentiation of MSCs into the osteogenic lineage .…”
Section: Introductionmentioning
confidence: 99%
“…Although small bone lesions heal autonomously, regeneration of large defects necessitate medical intervention. 13 Normally, mesenchymal stem cells (MSCs) are good cell candidates to provide osteoblasts responsible for bone regeneration 12,15,34 ; the commitment to an osteo lineage is a complex process for which the fate of cells is strictly controlled by numerous hormones and growth factors. 11,25,26,38 Recently, a small molecule termed 2,6,9-trisubstituted purine or purmorphamine, as an agonist of sonic hedgehog (Shh) has gained a special position in the field of medicinal chemistry.…”
Section: Introductionmentioning
confidence: 99%